DERMA PHARM A/S — Credit Rating and Financial Key Figures
CVR number: 89453119
Europavej 10, Purhus 8990 Fårup
crl@dermapharm.dk
tel: 86477744
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 63 641.00 | 76 155.00 | 70 657.00 | 71 576.42 | 81 333.29 |
| Employee benefit expenses | -58 100.74 | -60 067.69 | |||
| Total depreciation | -7 213.90 | -7 437.36 | |||
| EBIT | 9 954.00 | 15 839.00 | 9 867.00 | 6 261.77 | 13 828.24 |
| Other financial income | 297.60 | 955.84 | |||
| Other financial expenses | -1 050.99 | -2 646.62 | |||
| Net income from associates (fin.) | - 487.00 | - 635.81 | |||
| Pre-tax profit | 6 051.00 | 11 971.00 | 7 227.00 | 5 021.38 | 11 501.66 |
| Income taxes | - 998.96 | -1 927.24 | |||
| Net earnings | 6 051.00 | 11 971.00 | 7 227.00 | 4 022.42 | 9 574.42 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 9 296.16 | 9 973.77 | |||
| Intangible rights | 848.07 | 787.08 | |||
| Intangible assets total | 10 144.22 | 10 760.85 | |||
| Buildings | 24 035.51 | 23 277.91 | |||
| Machinery and equipment | 1 260.70 | 1 574.21 | |||
| Tangible assets total | 25 296.22 | 24 852.12 | |||
| Participating interests | 300.00 | 300.00 | |||
| Other receivables | 84 621.00 | 85 785.00 | 97 384.00 | ||
| Investments total | 84 621.00 | 85 785.00 | 97 384.00 | 300.00 | 300.00 |
| Non-curr. owed by group member comp. | 2 665.10 | 2 665.10 | |||
| Non-current other receivables | 188.76 | 18.42 | |||
| Long term receivables total | 2 853.86 | 2 683.52 | |||
| Semifinished products | 1 498.13 | 1 456.00 | |||
| Raw materials and consumables | 41 384.37 | 50 028.87 | |||
| Finished products/goods | 12 410.89 | 8 148.88 | |||
| Inventories total | 55 293.38 | 59 633.75 | |||
| Current trade debtors | 22 475.81 | 23 355.11 | |||
| Current amounts owed by group member comp. | 3 202.11 | 2 525.53 | |||
| Prepayments and accrued income | 881.86 | 1 475.33 | |||
| Current other receivables | 412.67 | 867.45 | |||
| Current deferred tax assets | 1 632.45 | ||||
| Short term receivables total | 28 604.89 | 28 223.42 | |||
| Cash and bank deposits | 46.71 | 3 340.15 | |||
| Cash and cash equivalents | 46.71 | 3 340.15 | |||
| Balance sheet total (assets) | 84 621.00 | 85 785.00 | 97 384.00 | 122 539.29 | 129 793.81 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 32 609.00 | 40 480.00 | 39 607.00 | 1 000.00 | 1 000.00 |
| Shares repurchased | 2 500.00 | ||||
| Other reserves | 7 251.00 | 7 779.54 | |||
| Retained earnings | -6 051.00 | -11 971.00 | -7 227.00 | 24 755.65 | 28 249.53 |
| Profit of the financial year | 6 051.00 | 11 971.00 | 7 227.00 | 4 022.42 | 9 574.42 |
| Shareholders equity total | 32 609.00 | 40 480.00 | 39 607.00 | 39 529.07 | 46 603.49 |
| Provisions | 3 439.00 | 2 293.96 | |||
| Capital loans | 4 000.00 | 2 000.00 | |||
| Non-current leasing loans | 8 225.08 | 7 675.76 | |||
| Non-current other liabilities | 4 545.51 | 4 618.53 | |||
| Non-current liabilities total | 16 770.59 | 14 294.29 | |||
| Current loans from credit institutions | 28 802.96 | 25 458.16 | |||
| Advances received | 43.56 | ||||
| Current trade creditors | 21 149.20 | 30 879.06 | |||
| Current owed to group member | 2 890.39 | ||||
| Short-term deferred tax liabilities | 322.28 | ||||
| Other non-interest bearing current liabilities | 9 914.52 | 9 942.58 | |||
| Current liabilities total | 62 800.63 | 66 602.07 | |||
| Balance sheet total (liabilities) | 32 609.00 | 40 480.00 | 39 607.00 | 122 539.29 | 129 793.81 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.